| Inventor | Institute |
|---|---|
| Mark Boyd | University of Liverpool |
| SKU: | 151708 |
|---|---|
| Product description: | MTBP is an MDM2 binding protein that alters p53/MDM2 homeostasis and may contribute to metastatic suppression. Recent studies have demonstrated that loss of MTBP expression in samples that are p53 positive and have low MDM2 is significantly associated with reduced patient survival in Squamous cell carcinoma of the head and neck (SCCHN). |
| Alternate name: | MDM2 Binding Protein, MDM2 (Mouse Double Minute 2)-Binding Protein, Mdm2, Transformed 3T3 Cell Double Minute 2, P53 Binding Protein (Mouse) Binding Protein, Mdm2, Transformed 3T3 Cell Double Minute 2, P53 Binding Protein Binding Protein, MDM2BP, HMTBP |
| Conjugation: | Unconjugated |
| Isotype: | IgG1 kappa |
| Immunogen: | Recombinant full-length human MTBP |
| Cat. #: | 151708 |
|---|---|
| Provenance and Ownership: | The Anti-MTBP [2C1E11] is owned by Cancer Research UK. CancerTools supplies the Anti-MTBP [2C1E11] under licence from Cancer Research UK and is the authorised source for its distribution. Sourcing Anti-MTBP [2C1E11] directly from the IP owner ensures authenticity, provenance and compliance with all applicable licensing and research use requirements. |
| Tool sub type: | Primary antibody |
| Unit size: | 100 ug |
| Research Fields: | Cancer; Cell biology; Genetics |
| Application: | WB |
| Target: | MTBP |
| Reactivity: | Human |
| Clone: | 2C1E11 |
| Host: | Mouse |
| Class: | Monoclonal |
| Target background: | MTBP is an MDM2 binding protein that alters p53/MDM2 homeostasis and may contribute to metastatic suppression. Recent studies have demonstrated that loss of MTBP expression in samples that are p53 positive and have low MDM2 is significantly associated with reduced patient survival in Squamous cell carcinoma of the head and neck (SCCHN). |
|---|
| Format: | Liquid |
|---|---|
| Concentration: | 1.1 mg/ml |
| Storage buffer: | PBS with 0.02% azide |
| Storage conditions: | -15° C to -25° C |
| Shipping conditions: | Dry ice |
| References: |
Vlatkovic et al. 2011. Cancer. 117(13):2939-50. PMID: 21692053. Loss of MTBP expression is associated with reduced survival in a biomarker-defined subset of patients with squamous cell carcinoma of the head and neck. |
|---|
| Cat. # | Tool Name | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 152835 | Anti-MTBP [2C1G6] |
Key Info
Anti-MTBP [2C1G6]
|
View Tool | |||||||||||||
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.